Kelly Edwards Irwin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mental Disorders | 15 | 2024 | 6796 | 1.790 |
Why?
|
Smoking Cessation | 5 | 2023 | 2064 | 1.160 |
Why?
|
Neoplasms | 17 | 2023 | 22072 | 1.050 |
Why?
|
Early Detection of Cancer | 5 | 2021 | 3202 | 0.830 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 93 | 0.760 |
Why?
|
Patient-Centered Care | 2 | 2019 | 1416 | 0.600 |
Why?
|
Group Homes | 4 | 2024 | 59 | 0.550 |
Why?
|
Carcinoma, Ductal | 1 | 2016 | 97 | 0.530 |
Why?
|
Healthcare Disparities | 8 | 2023 | 3388 | 0.530 |
Why?
|
Lung Neoplasms | 7 | 2021 | 13262 | 0.530 |
Why?
|
Schizophrenia | 3 | 2019 | 6915 | 0.450 |
Why?
|
Medical Oncology | 2 | 2022 | 2313 | 0.440 |
Why?
|
Tobacco Use Disorder | 1 | 2019 | 700 | 0.440 |
Why?
|
Mental Health | 3 | 2023 | 3213 | 0.380 |
Why?
|
Palliative Care | 8 | 2021 | 3607 | 0.360 |
Why?
|
Qualitative Research | 4 | 2024 | 2963 | 0.350 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5325 | 0.310 |
Why?
|
Clinical Trials as Topic | 4 | 2023 | 8056 | 0.280 |
Why?
|
Self Care | 2 | 2022 | 793 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3164 | 0.240 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4744 | 0.240 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2021 | 2003 | 0.240 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15840 | 0.230 |
Why?
|
Health Services Accessibility | 3 | 2023 | 5397 | 0.220 |
Why?
|
Cost of Illness | 1 | 2013 | 1940 | 0.210 |
Why?
|
Caregivers | 3 | 2023 | 2224 | 0.210 |
Why?
|
Vulnerable Populations | 3 | 2022 | 696 | 0.200 |
Why?
|
Breast Neoplasms | 3 | 2023 | 21025 | 0.200 |
Why?
|
Quality of Life | 3 | 2019 | 13308 | 0.200 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 5251 | 0.190 |
Why?
|
Temperance | 1 | 2020 | 87 | 0.180 |
Why?
|
Humans | 38 | 2024 | 760621 | 0.180 |
Why?
|
Long-Term Care | 1 | 2024 | 632 | 0.170 |
Why?
|
Mental Health Services | 2 | 2021 | 1717 | 0.170 |
Why?
|
Feasibility Studies | 2 | 2021 | 5201 | 0.170 |
Why?
|
Bipolar Disorder | 1 | 2016 | 5078 | 0.160 |
Why?
|
Cooperative Behavior | 2 | 2019 | 1500 | 0.160 |
Why?
|
Lung | 2 | 2021 | 9994 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9276 | 0.160 |
Why?
|
Patient Care | 1 | 2022 | 624 | 0.140 |
Why?
|
Reward | 1 | 2023 | 963 | 0.140 |
Why?
|
Antigens, CD19 | 1 | 2019 | 424 | 0.140 |
Why?
|
Terminally Ill | 1 | 2008 | 240 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2019 | 421 | 0.130 |
Why?
|
Mass Screening | 2 | 2021 | 5423 | 0.120 |
Why?
|
Adaptation, Psychological | 2 | 2016 | 2628 | 0.110 |
Why?
|
Comorbidity | 2 | 2019 | 10551 | 0.110 |
Why?
|
Survival Analysis | 2 | 2019 | 10182 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 935 | 0.100 |
Why?
|
Counseling | 1 | 2020 | 1548 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 220352 | 0.100 |
Why?
|
Female | 19 | 2024 | 391270 | 0.100 |
Why?
|
Family | 1 | 2023 | 3189 | 0.100 |
Why?
|
Terminal Care | 2 | 2015 | 1758 | 0.100 |
Why?
|
Withholding Treatment | 1 | 2015 | 613 | 0.090 |
Why?
|
Stress, Psychological | 3 | 2021 | 4446 | 0.090 |
Why?
|
Male | 15 | 2024 | 359744 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2029 | 0.090 |
Why?
|
Adult | 9 | 2024 | 219994 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1779 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1454 | 0.080 |
Why?
|
Smoking | 3 | 2023 | 9073 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 951 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10344 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1257 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1376 | 0.070 |
Why?
|
Risk Assessment | 2 | 2019 | 24123 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2890 | 0.070 |
Why?
|
Nursing Homes | 2 | 2024 | 1082 | 0.070 |
Why?
|
Patient Compliance | 1 | 2016 | 2688 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2514 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7806 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10547 | 0.060 |
Why?
|
United States | 3 | 2024 | 72461 | 0.060 |
Why?
|
Parents | 1 | 2008 | 3549 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3061 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3836 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2016 | 3726 | 0.060 |
Why?
|
Primary Health Care | 1 | 2019 | 4647 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15687 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2511 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7475 | 0.050 |
Why?
|
Depression | 2 | 2018 | 8044 | 0.050 |
Why?
|
Quarantine | 1 | 2023 | 176 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 3701 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12965 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 29658 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25942 | 0.050 |
Why?
|
Massachusetts | 2 | 2024 | 8803 | 0.050 |
Why?
|
Incidence | 1 | 2019 | 21392 | 0.040 |
Why?
|
Hospitalization | 2 | 2018 | 10790 | 0.040 |
Why?
|
Cotinine | 1 | 2020 | 203 | 0.040 |
Why?
|
Health Personnel | 2 | 2024 | 3310 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 580 | 0.040 |
Why?
|
Bupropion | 1 | 2020 | 304 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3986 | 0.040 |
Why?
|
Aged | 5 | 2024 | 169152 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39261 | 0.040 |
Why?
|
Telephone | 1 | 2020 | 624 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2024 | 2659 | 0.030 |
Why?
|
Infection Control | 1 | 2023 | 983 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 820 | 0.030 |
Why?
|
Resuscitation Orders | 1 | 2008 | 270 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13502 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 734 | 0.030 |
Why?
|
Attitude to Death | 1 | 2008 | 400 | 0.030 |
Why?
|
Anxiety | 2 | 2021 | 4538 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11712 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2022 | 1504 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8624 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17165 | 0.030 |
Why?
|
Family Characteristics | 1 | 2008 | 1001 | 0.030 |
Why?
|
Comprehension | 1 | 2008 | 618 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1894 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2001 | 0.020 |
Why?
|
Biological Products | 1 | 2019 | 916 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3865 | 0.020 |
Why?
|
Data Collection | 1 | 2008 | 3315 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4283 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3448 | 0.020 |
Why?
|
Hospice Care | 1 | 2015 | 692 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5253 | 0.020 |
Why?
|
Child | 3 | 2022 | 79806 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14495 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4035 | 0.020 |
Why?
|
Psychometrics | 1 | 2016 | 3051 | 0.020 |
Why?
|
Boston | 1 | 2008 | 9280 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6479 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3925 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2015 | 5425 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65017 | 0.010 |
Why?
|
Physicians | 1 | 2008 | 4591 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8035 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29932 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4775 | 0.010 |
Why?
|
Infant | 1 | 2008 | 36060 | 0.010 |
Why?
|
Cohort Studies | 1 | 2008 | 41335 | 0.010 |
Why?
|
Child, Preschool | 1 | 2008 | 42063 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54303 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40165 | 0.010 |
Why?
|
Adolescent | 1 | 2008 | 87810 | 0.010 |
Why?
|